GU Cancers Symposium 2014 - An indirect treatment comparison and cost-effectiveness analysis of abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer post-chemotherapy - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Tracy Li, Melissa Thompson, Mary Beth Todd, Margaret K. Yu, Thian San Kheoh, Jianming He, and Ryan Saadi at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

gucancer 2014 -2014 AA Cost-effectiveness-poster Li thumb

Janssen Global Services, Raritan, NJ; Cornerstone Research Group, Inc., Burlington, ON, Canada; Janssen Research & Development, LLC, Los Angeles, CA; Jassen Global Services, Raritan, NJ

 

Conference Coverage
 
Recent data from conferences worldwide
  • 2020 Virtual Congress / September 19-21
  • 2020 BCAN Think Tank Virtual / August 7
  • 2020 Virtual Education Program / August 8-10
  • 2020 Annual Meeting / July 17-19 / EAU Virtual Program
  • SUO - AUA 2020 Summer Webcast / July 18
  • 2020 Annual Meeting / June 27-28 / AUA Live Virtual Program
  • 2020 Annual Meeting / May 29-31 / Virtual Scientific Program
  • 2020 Annual Meeting / February 13-15 / San Francisco, CA
  • 2019 Annual Meeting / December 4-6 / Washington, DC
  • 2019 Annual Meeting / October 3 - October 5 / Aarhus, Denmark
  • 2019 Annual Congress / September 27 - October 1 / Barcelona, Spain
  • 2019 Biennial Meeting / August 29-31 / Basel, Switzerland